These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 24735005

  • 1. Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial.
    Ticly FG, Lira RP, Zanetti FR, Machado MC, Rodrigues GB, Arieta CE.
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):495-501. PubMed ID: 24735005
    [Abstract] [Full Text] [Related]

  • 2. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
    Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M, Acular LS for Cystoid Macular Edema (ACME) Study Group.
    Am J Ophthalmol; 2008 Oct; 146(4):554-560. PubMed ID: 18599019
    [Abstract] [Full Text] [Related]

  • 3. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.
    Heier JS, Topping TM, Baumann W, Dirks MS, Chern S.
    Ophthalmology; 2000 Nov; 107(11):2034-8;discussion 2039. PubMed ID: 11054327
    [Abstract] [Full Text] [Related]

  • 4. Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema.
    Ramakrishnan S, Baskaran P, Talwar B, Venkatesh R.
    Asia Pac J Ophthalmol (Phila); 2015 Nov; 4(4):216-20. PubMed ID: 26225780
    [Abstract] [Full Text] [Related]

  • 5. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery.
    Almeida DR, Johnson D, Hollands H, Smallman D, Baxter S, Eng KT, Kratky V, ten Hove MW, Sharma S, El-Defrawy S.
    J Cataract Refract Surg; 2008 Jan; 34(1):64-9. PubMed ID: 18165083
    [Abstract] [Full Text] [Related]

  • 6. Pseudophakic cystoid macular edema: ketorolac alone vs. ketorolac plus prednisolone.
    Singal N, Hopkins J.
    Can J Ophthalmol; 2004 Apr; 39(3):245-50. PubMed ID: 15180141
    [Abstract] [Full Text] [Related]

  • 7. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
    Tzelikis PF, Vieira M, Hida WT, Motta AF, Nakano CT, Nakano EM, Alves MR.
    Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN, Pendelton RA, Jenkins JE.
    J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
    [Abstract] [Full Text] [Related]

  • 9. Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes.
    Shimura M, Nakazawa T, Yasuda K, Nishida K.
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):284-91. PubMed ID: 17593013
    [Abstract] [Full Text] [Related]

  • 10. Comparison of ketorolac 0.45% versus diclofenac 0.1% for macular thickness and volume after uncomplicated cataract surgery.
    Lee TH, Choi W, Ji YS, Yoon KC.
    Acta Ophthalmol; 2016 May; 94(3):e177-82. PubMed ID: 26072977
    [Abstract] [Full Text] [Related]

  • 11. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.
    Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T.
    J Cataract Refract Surg; 2006 Sep; 32(9):1474-82. PubMed ID: 16931258
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP, De Castro LE, Vroman DT, Solomon KD.
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial.
    Erichsen JH, Holm LM, Forslund Jacobsen M, Forman JL, Kessel L.
    JAMA Ophthalmol; 2021 Oct 01; 139(10):1062-1070. PubMed ID: 34383010
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial.
    Kim SJ, Lo WR, Hubbard GB, Srivastava SK, Denny JP, Martin DF, Yan J, Bergstrom CS, Cribbs BE, Schwent BJ, Aaberg TM.
    Arch Ophthalmol; 2008 Sep 01; 126(9):1203-8. PubMed ID: 18779478
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery.
    Weber M, Kodjikian L, Kruse FE, Zagorski Z, Allaire CM.
    Acta Ophthalmol; 2013 Feb 01; 91(1):e15-21. PubMed ID: 22970738
    [Abstract] [Full Text] [Related]

  • 20. Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial.
    Zanetti FR, Fulco EA, Chaves FR, da Costa Pinto AP, Arieta CE, Lira RP.
    Indian J Ophthalmol; 2012 Jul 01; 60(4):277-81. PubMed ID: 22824596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.